VEGFA and coronary artery disorder: Compared to conventional treatments such as coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), angiogenic approaches show the potential for fewer side effects and complications.[5, 6] Angiogenic drugs, such as vascular endothelial growth factor (VEGF) and fibroblast growth faction (FGF), have shown promise in the treatment of ischemic heart disease.